{"id":570,"date":"2024-02-12T16:27:42","date_gmt":"2024-02-12T16:27:42","guid":{"rendered":"https:\/\/gebro.es\/?page_id=570"},"modified":"2024-02-14T12:59:10","modified_gmt":"2024-02-14T12:59:10","slug":"licensing-out","status":"publish","type":"page","link":"https:\/\/gebro.es\/en\/business-development-and-innovation\/licensing-out\/","title":{"rendered":"Licensing out"},"content":{"rendered":"
\n
<\/i><\/a><\/span><\/span><\/div>\n<\/section>\n\n
\n
\n
\n
\n

\n Licensing-Out<\/h1>\n <\/div>\n
\n
\n

The Gebro Holding Group markets its own brands and also enters into agreements with third parties for their marketing.<\/p>\n\n <\/div>\n \n <\/div>\n <\/div>\n<\/section>\n\n\n

\n\n
\n

RX Products<\/h2>\n <\/div>\n\n
\n \n
\n \"\"\n <\/div>\n
\n

\n Seractil\u00ae\n <\/h3>\n

Active substance<\/strong>: dexibuprofen 200 mg, 300 mg, 400 mg
\nIndication<\/strong>: anti-inflammatory, analgesic, antipyretic
\nForm<\/strong>: film-coated tablets, sachets<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Nocutil\u00ae\n <\/h3>\n

Active substance<\/strong>: desmopressin
\nIndication<\/strong>: nocturnal enuresis (only for tablets),central diabetes insipidus
\nForm<\/strong>: nasal spray (0.1 mg\/ml), tablets (0.1 mg, 0.2 mg)<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Pridax\u00ae\n <\/h3>\n

Active substance<\/strong>: alprostadil 20 \u03bcg\/ml concentrate for infusion
\nIndication<\/strong>: treatment of peripheral arterial occlusive disease (Fontaine stages III-IV)
\nForm<\/strong>: ampoules containing ethanol<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Xylanaest\u00ae purum\n <\/h3>\n

Active substance<\/strong>: lidocaine-HCl (0.5%, 1%, 2%)
\nIndication<\/strong>: local anaesthetic (in AT, CH: specific for neural therapy also as Xyloneural\u00ae)
\nForm<\/strong>: ampoules, vials<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Mepinaest\u00ae\n <\/h3>\n

Active substance<\/strong>: oral rehydration mixture
\nIndication<\/strong>: replacement of fluid and electrolyte losses resulting from diarrhoea and vomiting
\nForm<\/strong>: sachets, 13,1 mg<\/p>\n<\/div>\n <\/div>\n<\/div>\n <\/section>\n\n\n

\n\n
\n

OTC-Products<\/h2>\n <\/div>\n\n
\n \n
\n \"\"\n <\/div>\n
\n

\n Normhydral\u00ae (for adolescents and adults)\n <\/h3>\n

Active substance<\/strong>: oral rehydration mixture
\nIndication<\/strong>: replacement of fluid and electrolyte losses resulting from diarrhoea and vomiting
\nForm<\/strong>: sachets, 13,1 mg<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Normolyt\u00ae (for infants and children)\n <\/h3>\n

Active substance<\/strong>: oral rehydration mixture
\nIndication<\/strong>: replacement of fluid and electrolyte losses resulting from diarrhoea and vomiting Form<\/strong>: sachets, 5,4 m<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Laxasan\u00ae\n <\/h3>\n

Active substance<\/strong>: natrium picosulfate
\nIndication<\/strong>: obstipation
\nForm<\/strong>: drops<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Eu-Med\u00ae\n <\/h3>\n

Active substance<\/strong>: Dexibuprofen 200 mg
\nIndication<\/strong>: treatment of pain and fever in colds and flu-like infections
\nForm<\/strong>: film-coated tablets<\/p>\n<\/div>\n <\/div>\n<\/div>\n

\n \n
\n \"\"\n <\/div>\n
\n

\n Makutussin\u00ae (swiss registration)\n <\/h3>\n

Active substance<\/strong>: codeine phosphate hemihydrate
\nIndication<\/strong>: cough relief, especially for dry cough
\nForm<\/strong>: drops<\/p>\n<\/div>\n <\/div>\n<\/div>\n <\/section>\n\n\n

\n\n
\n

OTC-products (herbal medicines)<\/h2>\n <\/div>\n\n
\n \n
\n \"\"\n <\/div>\n
\n

\n Thyme drops\u00ae\n <\/h3>\n

Active substance<\/strong>: Thyme extract 972 mg\/g Indication: cough
\nForm<\/strong>: drops (traditional herbal medicine, alcohol-containing)<\/p>\n<\/div>\n <\/div>\n<\/div>\n <\/section>\n\n\n

\n
\n

Alpinamed AG<\/h2>\n

Competence in herbal extracting High quality health products<\/p>\n

\n

Alpinamed AG belongs to the Austrian Gebro Holding GmbH. The company is nowadays one of the leading manufacturers of standard and special extracts. These are used in many pharmaceutical products, in nutri- tional supplements and in innovative cosmetic products.
\nAs a system supplier, we offer complete tailor-made solutions:<\/p>\n

    \n
  • Extracts in liquid or dry form<\/li>\n
  • Derived products as bulk supplies<\/li>\n
  • Sales-ready finished products<\/li>\n<\/ul>\n\n <\/div>\n <\/div>\n
    \n \"\"\n <\/div>\n<\/section>\n\n\n
    \n\n
    \n

    Food Suplements (natural ingredients)<\/p>\n

    Gluten-free and lactose free<\/p>\n <\/div>\n\n

    \n \n
    \n \"\"\n <\/div>\n
    \n

    \n Alpinamed\u00ae Lingonberry product line\n <\/h3>\n

    Ingredients<\/strong>: extract of fresh lingonberries
    \nUse<\/strong>: food supplement
    \nForm<\/strong>: tablets, sachets, concentrate for oral solution, toffees<\/p>\n<\/div>\n <\/div>\n<\/div>\n

    \n \n
    \n \"\"\n <\/div>\n
    \n

    \n Alpinamed\u00ae Curcuma product line\n <\/h3>\n

    Ingredients<\/strong>: turmeric root extract & curcumin
    \nUse<\/strong>: food supplement for the support of intestinal & musculoskeletal health
    \nForm<\/strong>: capsules, liquid<\/p>\n<\/div>\n <\/div>\n<\/div>\n

    \n \n
    \n \"\"\n <\/div>\n
    \n

    \n Aplinamed\u00ae Black Garlic\n <\/h3>\n

    Ingredients<\/strong>: black garlic (fermented garlic), Vitamin B1 + B2,
    \nUse<\/strong>: dietary support for a healthy heart and nervous system
    \nForm<\/strong>: soft gel capsules<\/p>\n<\/div>\n <\/div>\n<\/div>\n <\/section>\n\n\n

    \n
    \n

    Contact manufacture<\/h2>\n

    Flexibility and costumer-oriented service is our strenght<\/p>\n

    \n \n <\/div>\n <\/div>\n
    \n \"\"\n <\/div>\n<\/section>\n\n\n
    \n
    \n

    Production<\/h3>\n

    Gebro Pharma produces medicinal products, food suplements\/dietary products and cosmetics in various pharmaceutical forms. We supply partners in more than 20 countries worldwide, in compliance with crrent Good manufacturing Practices (cGMP).<\/p>\n<\/p>\n <\/div>\n

    \n
    \n \"\"\n <\/div>\n
    \n

    \n Solid Forms\n <\/p>\n

    (Maximum batch of 400 kg)<\/p>\n

      \n
    • Tablets<\/li>\n
    • Film coated tablets<\/li>\n
    • Blister packaging of various forms<\/li>\n
    • Power in tins<\/li>\n<\/ul>\n<\/div>\n <\/div>\n <\/div>\n
      \n
      \n \"\"\n <\/div>\n
      \n

      \n Injection solutions\n <\/p>\n

      Injection solutions Terminal sterile products with a maximum batch size of 500 litres:<\/p>\n

        \n
      • aqueous solutions<\/li>\n
      • glass ampoules<\/li>\n
      • vials<\/li>\n<\/ul>\n<\/div>\n <\/div>\n <\/div>\n
        \n
        \n \"\"\n <\/div>\n
        \n

        \n Liquid Forms\n <\/p>\n

        Power in tins (maximum batch size of 2.000 litres):<\/p>\n

          \n
        • aqueous solution<\/li>\n
        • alcohol solution<\/li>\n
        • glass or plastic bottles in combination with various types of seal, such as drip plug, nasal spray<\/li>\n<\/ul>\n<\/div>\n <\/div>\n <\/div>\n <\/section>\n\n\n
          \n
          \n

          Services<\/h3>\n <\/div>\n
          \n
          \n \"\"\n <\/div>\n
          \n

          \n Analysis\n <\/p>\n

          Incoming goods control of raw materials<\/p>\n

            \n
          • GMP-compliant batch release<\/li>\n
          • Stability tests<\/li>\n
          • Analytical method development<\/li>\n<\/ul>\n<\/div>\n <\/div>\n <\/div>\n
            \n
            \n \"\"\n <\/div>\n
            \n

            \n Distribution\n <\/p>\n

            In association with our wholesale activity we are also pleased to offer you for the Austrian market:<\/p>\n

              \n
            • Storage and distribution of pharmaceutical products,<\/li>\n
            • also as refrigerated products depending on the quantity<\/li>\n<\/ul>\n<\/div>\n <\/div>\n <\/div>\n
              \n
              \n \"\"\n <\/div>\n
              \n

              \n Regulatory support\n <\/p>\n

                \n
              • Life cycle management support (change report)<\/li>\n<\/ul>\n<\/div>\n <\/div>\n <\/div>\n <\/section>\n\n\n
                \n
                \n

                Innovation and development<\/h2>\n

                Rethink, reinvent, optimize drugs<\/p>\n

                \n

                We are putting patients and healthcare professionals at the centre of it\u2019s momentum. We are passionate about creating our own innovation projects by partnering with recognised public and private research groups and with national institutions of the highest level.<\/p>\n

                In our headquarters in Austria, we offer full development services – from the idea to the finished product.
                \nA galencial laboratory equipped with state of the art technology.<\/p>\n

                  \n
                • Development, scale-up and troubleshooting of solid, liquid and semi-solid dosage forms.<\/li>\n
                • Recipe development including production od pre.stability samples.<\/li>\n
                • Scale-up and support of the product transfer to our production facilities through to process validation.<\/li>\n
                • Development and validation of all common analytical methods.<\/li>\n
                • Chemical-physical analysis of test series, pre-stability and iCH stability sample.<\/li>\n<\/ul>\n\n <\/div>\n <\/div>\n
                  \n \"\"\n <\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":128,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-business.blade.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-570","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nLicensing out - Gebro Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gebro.es\/en\/business-development-and-innovation\/licensing-out\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Licensing out - Gebro Pharma\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gebro.es\/en\/business-development-and-innovation\/licensing-out\/\" \/>\n<meta property=\"og:site_name\" content=\"Gebro Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-14T12:59:10+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/business-development-and-innovation\\\/licensing-out\\\/\",\"url\":\"https:\\\/\\\/gebro.es\\\/en\\\/business-development-and-innovation\\\/licensing-out\\\/\",\"name\":\"Licensing out - Gebro Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/#website\"},\"datePublished\":\"2024-02-12T16:27:42+00:00\",\"dateModified\":\"2024-02-14T12:59:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/business-development-and-innovation\\\/licensing-out\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/gebro.es\\\/en\\\/business-development-and-innovation\\\/licensing-out\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/business-development-and-innovation\\\/licensing-out\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\",\"item\":\"https:\\\/\\\/gebro.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Business Development and Innovation\",\"item\":\"https:\\\/\\\/gebro.es\\\/en\\\/business-development-and-innovation\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Licensing out\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/gebro.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/gebro.es\\\/en\\\/\",\"name\":\"Gebro Pharma\",\"description\":\"At Gebro Pharma we improve your health\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/gebro.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Licensing out - Gebro Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gebro.es\/en\/business-development-and-innovation\/licensing-out\/","og_locale":"en_US","og_type":"article","og_title":"Licensing out - Gebro Pharma","og_url":"https:\/\/gebro.es\/en\/business-development-and-innovation\/licensing-out\/","og_site_name":"Gebro Pharma","article_modified_time":"2024-02-14T12:59:10+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/gebro.es\/en\/business-development-and-innovation\/licensing-out\/","url":"https:\/\/gebro.es\/en\/business-development-and-innovation\/licensing-out\/","name":"Licensing out - Gebro Pharma","isPartOf":{"@id":"https:\/\/gebro.es\/en\/#website"},"datePublished":"2024-02-12T16:27:42+00:00","dateModified":"2024-02-14T12:59:10+00:00","breadcrumb":{"@id":"https:\/\/gebro.es\/en\/business-development-and-innovation\/licensing-out\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gebro.es\/en\/business-development-and-innovation\/licensing-out\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/gebro.es\/en\/business-development-and-innovation\/licensing-out\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"","item":"https:\/\/gebro.es\/en\/"},{"@type":"ListItem","position":2,"name":"Business Development and Innovation","item":"https:\/\/gebro.es\/en\/business-development-and-innovation\/"},{"@type":"ListItem","position":3,"name":"Licensing out"}]},{"@type":"WebSite","@id":"https:\/\/gebro.es\/en\/#website","url":"https:\/\/gebro.es\/en\/","name":"Gebro Pharma","description":"At Gebro Pharma we improve your health","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gebro.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/pages\/570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/comments?post=570"}],"version-history":[{"count":5,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/pages\/570\/revisions"}],"predecessor-version":[{"id":666,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/pages\/570\/revisions\/666"}],"up":[{"embeddable":true,"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/pages\/128"}],"wp:attachment":[{"href":"https:\/\/gebro.es\/en\/wp-json\/wp\/v2\/media?parent=570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}